A case series of therapeutic outcomes of head and neck cancer patients with unnoticed hiv infection

HIGHLIGHTS

• who: Head et al. from the Immune suppression secondary to Human Immunodeficiency Virus (HIV) infection is associated with an two to five fold risk of head and neck cancer (HNC) [1]In one case series with , HIV patients with head and neck cancer (HIVHNC), patients with lower , cell count at time of cancer diagnosis (andlt have published the article: A Case Series of Therapeutic Outcomes of Head and Neck Cancer Patients with Unnoticed HIV Infection, in the Journal: (JOURNAL)
• what: The authors report 4 HIV-HNC patients who received cancer treatment from 2007 until 2017 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.